Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy - Forschungsportal der Justus-Liebig-Universität Gießen:

Journalartikel

Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy

Autorenliste: Steinchen, N.; Mueller-Ladner, U.; Lange, U.

Jahr der Veröffentlichung: 2020

Seiten: 574-577

Zeitschrift: Zeitschrift für Rheumatologie

Bandnummer: 79

Heftnummer: 6

ISSN: 0340-1855

eISSN: 1435-1250

Open Access Status: Hybrid

DOI Link: https://doi.org/10.1007/s00393-020-00824-0

Verlag: Springer

Abstract:
A case with rheumatoid arthritis and insufficient compensation under disease-modifying combined long-term therapy with methotrexate and leflunomide is reported. After recovery from a COVID-19 infection, a tumor necrosis factor (TNF) inhibitor therapy was initiated. Until now no reactivation of the COVID-19 infection with positive SARS-CoV-2 antibody status has occurred.

Zitierstile

Harvard-Zitierstil: Steinchen, N., Mueller-Ladner, U. and Lange, U. (2020) Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy, Zeitschrift für Rheumatologie, 79(6), pp. 574-577. https://doi.org/10.1007/s00393-020-00824-0

APA-Zitierstil: Steinchen, N., Mueller-Ladner, U., & Lange, U. (2020). Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy. Zeitschrift für Rheumatologie. 79(6), 574-577. https://doi.org/10.1007/s00393-020-00824-0

Zitierstile

Schlagwörter